miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is a common hepatic disease with an increasing prevalence but an unclear aetiology. This study aimed to investigate the functional implications of microRNA-122 (miR-122) in the pathogenesis of NAFLD and the possible molecular mechanisms....
Saved in:
Main Authors: | Jun-Ke Long (Author), Wen Dai (Author), Ya-Wen Zheng (Author), Shui-Ping Zhao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
by: Xiahenazi Aiyasiding, et al.
Published: (2022) -
Regulation of hepatic glutamine metabolism by miR-122
by: Dipanwita Sengupta, et al.
Published: (2020) -
Lygodium microphyllum Inhibits de Novo Lipogenesis Activity in the Hepatocytes of High-Fat High-Fructose-Induced Rats by Increasing the Levels of SIRT1 and AMPK
by: Anggreini P, et al.
Published: (2024) -
Qiangjing tablets ameliorate asthenozoospermia via mitochondrial ubiquitination and mitophagy mediated by LKB1/AMPK/ULK1 signaling
by: Guangsen Li, et al.
Published: (2023) -
LKB1 and AMPKα1 are required in pancreatic alpha cells for the normal regulation of glucagon secretion and responses to hypoglycemia
by: Gao Sun, et al.
Published: (2015)